The committee supports approving the CFTR modulator for patients 2 years and older with at least one non-class I CFTR gene mutation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results